PERSIAN trial: Early results from a randomized phase II trial testing apalutamide and stereotactic body radiation therapy for low-burden, metastatic, hormone-sensitive prostate cancer.
2025; Lippincott Williams & Wilkins; Volume: 43; Issue: 5_suppl Linguagem: Inglês
10.1200/jco.2025.43.5_suppl.160
ISSN1527-7755
AutoresGiulio Francolini, Vanessa Di Cataldo, Pietro Garlatti, Saverio Caini, Alessio Bruni, Nicola Simoni, Matteo Augugliaro, Roberto Iacovelli, Luca Tagliaferri, Nicola Battelli, Gianluca Ingrosso, Angelo Porreca, Marco Trovò, Giuseppe Fornarini, Giuseppe Carlo Iorio, Alessia Guarneri, Michele Sisani, Lorenzo Antonuzzo, Alfio Di Grazia, Lorenzo Livi,
Tópico(s)Medical Imaging Techniques and Applications
Referência(s)